Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase IIa Study: Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02692976
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:30.672402+00:00
Published At
2019-11-14T00:00:00+00:00
Record Updated At
2019-11-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Prostatic Neoplasms", "Immunotherapy", "Dendritic Cells", "Vaccines"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-11-14"
protocolSection.identificationModule.nctId
"NCT02692976"
protocolSection.identificationModule.officialTitle
"A Randomized Phase IIa Study: Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Prostatic Neoplasms (protocolSection.conditionsModule.conditions)
  • Immunotherapy (protocolSection.conditionsModule.conditions)
  • Dendritic Cells (protocolSection.conditionsModule.conditions)
  • Vaccines (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.